Rituxan (rituximab) - Roche
prednisone - Generic mfg.
Fibrillary Glomerulonephritis with Focal Crescents and Concurrent c-ANCA, p-ANCA, and Myeloperoxidase (MPO) Positivity (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0717; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "The patient received pulse methylprednisolone followed by prednisone taper and rituximab. While ANCA positivity in FGN is rare, the presence of high-titer ANCA serologies together with crescents and necrosis raised concern for superimposed ANCA-mediated inflammation. Recognition of these overlapping features is important because they may influence immunosuppressive management and renal outcomes." 
Cardiovascular • Chronic Kidney Disease • Chronic Obstructive Pulmonary Disease • Fibrosis • Glomerulonephritis • Hypertension • Immunology • Inflammation • Lupus Nephritis • Nephrology • Pulmonary Disease • Renal Disease • Respiratory Diseases • MPO
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4557613
 
Shanzae Naeem; Nicholas Robinson; Om Vishwas Sakhalkar
 
Oct 2, 2026
 
Prev Next